27 results
2021 ACR Guidance for Adjusting Immunomodulatory Therapy related to the COVID-19 Vaccine in Patients with Rheumatic
Methotrexate, Mycophenolate ... @MithuRheum #ACR2021
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678035/

Mycophenolate versus Azathioprine as Maintenance Therapy
Mycophenolate Mofetil ... PMC2678035/ Mycophenolate ... NEJMoa1014460 #ALMS #Mycophenolate
2021 ACR/VF Guidelines for Management of Giant Cell Arteritis (GCA)

#GiantCell #Arteritis #GCA #ACR2021 #Management #rheumatology #algorithm
Arteritis #GCA #ACR2021
2021 ACR/VF Guidelines for Management of Polyarteritis Nodosa (PAN)

#PAN #Polyarteritis #Nodosa #ACR2021 #Management #rheumatology #algorithm #vasculitis
Polyarteritis #Nodosa #ACR2021
Rheumatoid Arthritis - ACR 2021 Guidelines
 - Low Disease Activity
 - Moderate to High Disease Activity
Rheumatoid #Arthritis #ACR2021
2021 ACR/VF Guidelines for Management of Eosinophilic Granulomatosis with Polyangiitis (EGPA)

#EGPA #Eosinophilic #Granulomatosis #Polyangiitis #ACR2021 #Management
#Polyangiitis #ACR2021
2021 ACR/VF Guidelines for Management of Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

#Granulomatosis #Polyangiitis #GPA
Polyangiitis #MPA #ACR2021
Immunosuppressive Medications in Systemic Lupus Erythematosus (SLE)
 - MTX (oral, subcutaneous)
 - AZA (oral) 
 -
voclosporin) - Mycophenolate ... (oral; mycophenolate
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Management #Treatment #ACR2021
Immune Reactions and Immunosuppressant Drugs

Glucocorticoids - Inhibition of cytokine synthesis, e.g., IL-1, IL-2
Muromonab-CD3 - Monoclonal antibody
Calcineurin
Cyclophosphamide, Mycophenolate